📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A repositioning screen using an FGFR2 splicing reporter reveals compounds that regulate epithelial-mesenchymal transitions and inhibit growth of prostate cancer xenografts. (2022)

First Author: Li L

Attributed to: Anti-angiogenic compounds based on modulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2022.03.005

PubMed Identifier: 35402635

Publication URI: http://europepmc.org/abstract/MED/35402635

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501